Reference number : 033-2011-2012-Q4-509585, amendment number : , agreement type : C, recipient legal name : Trillium Therapeutics Inc., recipient country : CA, recipient province : ON, recipient city : Mississauga, recipient postal code : M9W4Y9, program name english : Federal Economic Development Department for Ontario, program name french : Federal Economic Development Department for Ontario, program purpose english : nan, program purpose french : nan, agreement title english : 509585, agreement title french : 509585, agreement number : 509585, agreement value : 965000.0, agreement start date : 2011-11-01, agreement end date : 2013-12-31, description english : Trillium Therapeutics is a biotechnology company specializing in innovative therapies of immunology and ctyoprotection. Funds will help commercialize a therapeutic treatment for interstitial cystitis., description french : sans object, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada